Global morbidity gap widens study
Analysis based on 11 articles · First reported Jul 21, 2026 · Last updated Jul 23, 2026
The study highlights growing healthcare costs and demand for chronic disease management, potentially benefiting pharmaceutical and healthcare service companies. Insurers may face increased claims, while preventive health and wellness sectors could see investment.
A new Global Burden of Disease study published in The Lancet on July 21, 2026, reveals that while global life expectancy increased from 64.6 years in 1990 to 73.8 years in 2023, healthy life expectancy rose more slowly from 55.9 to 63.1 years, widening the morbidity gap from 8.8 to 10.7 years. The United States had the largest national morbidity gap at 14 years, followed by Australia at 13.9 years and Canada at 13.7 years. Women consistently live longer but spend more years in poor health than men. Key drivers include musculoskeletal disorders, mental health conditions, and preventable risk factors like high blood sugar and obesity. The study calls for greater investment in prevention and chronic care.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard